DSC Advisors, L.P. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$2,744,000
-59.3%
330,576
-50.0%
0.57%
-85.3%
Q4 2017$6,743,000
-29.4%
661,045
-36.7%
3.91%
+28.5%
Q3 2017$9,550,000
+25.3%
1,043,7700.0%3.04%
+21.3%
Q2 2017$7,620,000
+1.4%
1,043,7700.0%2.51%
-51.0%
Q1 2017$7,515,000
+85.2%
1,043,770
+50.5%
5.12%
+122.6%
Q4 2016$4,057,000
-21.4%
693,582
-11.6%
2.30%
-26.6%
Q3 2016$5,163,000
-19.8%
784,704
+13.1%
3.14%
-22.5%
Q2 2016$6,436,000
-14.0%
693,5820.0%4.05%
-8.9%
Q1 2016$7,484,000
-42.9%
693,582
-26.1%
4.44%
-35.1%
Q4 2015$13,105,000
-26.4%
938,5980.0%6.84%
-20.8%
Q3 2015$17,813,000938,5988.65%
Other shareholders

There were no reported owners of NEOS THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of NEOS THERAPEUTICS INC shareholders